Adipocyte-selective LRP1 knock-out mice exhibit decreased epididymal fat
and hepatosteatosis. A, aspect (arrows) and
(B), quantification of the epididymal fat and body weight in
20-week-old tamoxifen-treated aP2-CreERT2;
LRP1flox/flox;LDLr(-/-) mice (adLRP1(-/-)Tam).
C, H&E staining of epididymal WAT and BAT sections from
12-week-old tamoxifen-treated
aP2-CreERT2;LRP1flox/flox;LDLr(-/-) mice
(adLRP1(-/-)Tam) and tamoxifen-treated controls
(aP2CreERT2;LRP1flox/flox;LDLr(-/-)) mice
(adLRP1+/+Tam) fed 5 weeks with a high fat diet. D,
immunoblot analysis of p-AMPK, AMPK, p-ACC, and loading control in epididymal
WAT and BAT, and of LRP1 in BAT and purified epididymal WAT adipocytes from
adLRP1+/+Tam (lanes 1, 3) and adLRP1(-/-)Tam
(lanes 2, 4) mice. E, H&E (left) and Oil Red O
(middle and right) staining of liver sections from
adLRP1(+/+)Tam and adLRP1(-/-)Tam mice fed 5 weeks with
a high fat diet (HFD) or a regular chow diet (CD).
F, Oil Red O staining of liver sections from aP2Cre;
LRP1flox/flox;LDLr(+/+) mice. Panels show adLRP1+/+ (aP2Cre-;
LRP1flox/flox; LDLr(+/+)) and adLRP1(-/-) (aP2Cre+;
LRP1flox/flox;LDLr(+/+)) mice that had been fed a high fat diet
(HFD) for 4 weeks. Results are means ± S.D. *,
p < 0.05. Scale bar, 50 μm.